Seroepidemiology of hepatitis A and B in the general population in Hong Kong: protocol of a cross-sectional survey using spatial sampling in a highly urbanised city. Issue 3 (22nd March 2021)

• Record Type: Journal Article
• Authors: Poon, Chin Man; Chan, Denise P; Lee, Shui Shan; Wong, Ngai Sze
• Is Part Of: BMJ open. Volume 11:Issue 3(2021)
• Publication Date: 2021-03-22
• Subjects: epidemiology -- public health -- immunology -- hepatology; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2020-042065
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: Differences in immunisation policies have significantly reshaped the epidemiology of hepatitis A and B in the population. Assessment of the susceptibility and transmission potential of these two types of vaccine-preventable hepatitis would enhance the capacity of public health authorities for viral hepatitis elimination. Focusing on Hong Kong, the objectives of this study comprise the determination of the population-level seroprevalence of hepatitis A and B and an examination of the risk factors for virus transmission and the population impacts of vaccinations. Methods and analysis: This is a cross-sectional household survey on hepatitis A and B. By using socially homogeneous building groups as sampling frame, eligible members of 1327 spatially selected households would be invited to complete a questionnaire and provide blood samples for serological testing (anti-hepatitis A virus, hepatitis B surface antigen, hepatitis B surface and core antibody). The main measures comprise a set of metrics on the prevalence of hepatitis A and B. Analysis would be conducted to examine the association of risk factors with the tested markers and describe the attitudes towards viral hepatitis vaccination. Ethics and dissemination: Ethical approval from the Joint Chinese University of Hong Kong—New Territories East Cluster Clinical Research Ethics Committee, and approval for laboratory safety from the Chinese University of Hong Kong have been obtained. The study results will be presented in scientific forums to update on the epidemiology of hepatitis A and B and inform the development of new vaccination strategies in Hong Kong. Trial registration number: NCT04371276 .